Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China flag China · Delayed Price · Currency is CNY
35.30
-0.01 (-0.03%)
Sep 30, 2025, 3:00 PM CST
-0.03%
Market Cap24.38B
Revenue (ttm)1.84B
Net Income (ttm)304.75M
Shares Out733.37M
EPS (ttm)0.40
PE Ratio87.17
Forward PE74.66
Dividend0.03 (0.08%)
Ex-Dividend DateAug 14, 2025
Volume24,587,174
Average Volume45,677,603
Open35.31
Previous Close35.31
Day's Range34.84 - 36.18
52-Week Range14.95 - 42.90
Beta0.87
RSI48.90
Earnings DateOct 29, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,652
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603127
Full Company Profile

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial Statements

News

There is no news available yet.